OCREVUS® (ocrelizumab) Pregnancy Registry

Do you have multiple sclerosis (MS) and are you pregnant? Then you may be able to take part in a global registry of women with MS who are pregnant and either have or have not received OCREVUS® (ocrelizumab) during or within 6 months before their pregnancy.

Get More Info on the Registry

How do I participate?

Fill out the contact form to have a registry representative contact you with more information on the registry

Call the registry's toll-free number 1 (833) 872-4370 and speak to a registry representative

Ask your healthcare provider to help you complete the contact form

About pregnancy and multiple sclerosis

The effects of a particular medicine on the health of an unborn baby are often unknown because pregnant women are not usually included in clinical research studies to test a potential new medicine. Pregnancy registries aim to collect information that could help women and their healthcare providers make more informed decisions about using a particular medicine during pregnancy in the future.

Learn more about pregnancy & MS

For the most updated important safety information, please see full Prescribing Information and Medication Guide. This is not intended to replace discussions with your healthcare provider.

This site uses cookies including for the essential functioning of the site and for analytical purposes. For more information about these cookies and the choices you have to manage them, please view our Privacy Policy or visit the Interactive Advertising Bureau

By clicking through the website, we understand this means you have accepted our cookies.